XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2023
Operating activities:      
Net income (loss) $ 8,796 $ 3,278 $ 8,027
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Stock-based compensation expense 16,810 12,624 10,463
Loss on extinguishment of revolving credit line 309 0 0
Amortization of intangible assets 14,143 15,156 16,992
Amortization of costs capitalized to obtain revenue contracts [1] 1,896 1,662 1,514
Depreciation expense 1,315 1,755 1,727
Bad debt expense [1] 803 647 737
Amortization of investment premiums & other (1,107) (2,624) (722)
Accretion and amortization on debt securities 8,614 8,085 7,546
Net changes in estimated fair value of acquisition-related contingent consideration 0 136 2,056
Deferred taxes (9,576) (10,434) (5,496)
Changes in assets and liabilities, net of acquisitions:      
Accounts receivable [1] (5,697) 489 3,579
Contract assets 5,489 4,600 (12,471)
Other assets [1] (1,293) (1,534) (2,638)
Accounts payable (3,371) (450) 2,535
Accrued payroll and related taxes 6,362 240 18
Income taxes payable 2,530 (4,560) 5,577
Deferred revenue 7,949 3,221 (5,217)
Restructuring accrual 0 0 (977)
Other liabilities 1,368 (603) (1,664)
Net cash provided by (used in) operating activities 55,340 31,688 31,586
Investing activities:      
Purchases of investments (40,610) (62,433) (71,733)
Maturities of investments [1] 46,250 92,617 66,250
Sales of investments [1] 1,350 0 0
Acquisitions, net of cash acquired 0 0 (267)
Purchases of property and equipment, net (1,155) (1,438) (1,034)
Net cash provided by (used in) investing activities 5,835 28,746 (6,784)
Financing activities:      
Payment of debt issuance costs (224) (290) 0
Proceeds from the issuance of equity plan common stock 1,701 1,889 1,737
Repurchases and retirements of common stock (4,738) (24,180) 0
Payment of acquisition-related contingent consideration 0 (4,641) 0
Proceeds from other borrowings 1,691 1,496 0
Principal payments on other borrowings (276) (156) (36)
Net cash provided by (used in) financing activities (1,846) (25,882) 1,701
Foreign currency effect on cash and cash equivalents 1,368 (9) 351
Net increase in cash and cash equivalents 60,697 34,543 26,854
Cash and cash equivalents at beginning of period 93,456 58,913 32,059
Cash and cash equivalents at end of period 154,153 93,456 58,913
Supplemental disclosures of cash flow information:      
Cash paid for interest 1,164 1,274 1,413
Cash paid for income taxes 9,087 11,989 3,836
Supplemental disclosures of non-cash investing and financing activities:      
Acquisition-related shares issued 0 3,471 0
Unrealized holding gain (loss) on available-for-sale investments $ (68) $ 301 $ 889
[1] Consolidated statement of cash flows for the twelve months ended September 30, 2023 reflect revisions and reclassifications to conform to the current year presentation.